FCMV
KNTE
Foresite Capital Management V’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,525,957
| Closed | -$9.38M | – | 7 |
|
|
2024
Q1 | $9.38M | Hold |
3,525,957
| – | – | 8.8% | 4 |
|
|
2023
Q4 | $8.36M | Hold |
3,525,957
| – | – | 11.39% | 4 |
|
|
2023
Q3 | $4.94M | Hold |
3,525,957
| – | – | 7.88% | 5 |
|
|
2023
Q2 | $10.7M | Buy |
3,525,957
+1,550,956
| +79% | +$4.7M | 7.8% | 6 |
|
|
2023
Q1 | $12.3M | Buy |
1,975,001
+1,100,000
| +126% | +$6.88M | 9.13% | 4 |
|
|
2022
Q4 | $5.34M | Hold |
875,001
| – | – | 4.15% | 7 |
|
|
2022
Q3 | $10.5M | Hold |
875,001
| – | – | 8.04% | 5 |
|
|
2022
Q2 | $11M | Hold |
875,001
| – | – | 7.71% | 7 |
|
|
2022
Q1 | $9.85M | Hold |
875,001
| – | – | 4.02% | 9 |
|
|
2021
Q4 | $15.5M | Hold |
875,001
| – | – | 3.81% | 8 |
|
|
2021
Q3 | $20.1M | Hold |
875,001
| – | – | 6.26% | 5 |
|
|
2021
Q2 | $20.4M | Hold |
875,001
| – | – | 8.01% | 4 |
|
|
2021
Q1 | $27.3M | Hold |
875,001
| – | – | 8.02% | 4 |
|
|
2020
Q4 | $34.8M | Buy |
+875,001
| New | +$34.8M | 25.78% | 1 |
|